跳至主要内容
临床试验/CTRI/2022/11/047213
CTRI/2022/11/047213尚未招募2/3 期

Clinical Study To Evaluate The Effect Of Udavarta Roga Nashaka Arka In Udavartini Yoni Vyapath (Primary Dysmenorrhoea)

Dr ASWINI S1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年11月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To see the reduction in the insensitive of pain

研究概览

简要总结

Udavarthini yoni vyapath is one among the vataja yoni vyapath.Normal menstruation is thefunction of Apana vata therefore painful menstruation is considered as Apana vatadushti. As movement of vata is in reverse direction of the course of uterine contraction, the womanbecomes afflicted with pain and discharges the menstrual blood with great difficulty that is tending in a reverse direction. Apana vata is having the function of nishkramana of artava and its vitiation will lead to Udavartini yoni vyapath.Nidana, Samprapthi and Rupa of Udavartini yoni vyapat can be well explained with the etiopathogenesis and clinical features of Primary dysmenorrhoea.Primary dysmenorrhea is painful menstruation without any underlying pelvic pathology associated with nausea, vomiting, headache, fatigue. Previously many studies have been conducted for the same condition on Shodhana karmas mainly Vasthi and other oral medications. Arka kalpana is avery unique form of medicine by its palatability, increased potency and reduced dose. So as we are searching for more convenient forms of medication, Udavarta roga nasaka arka mentioned in Arka prakasha is selected for present study. The drugs included are Trikatu, Pippali mula, Trivrut, Danti and Chitraka with Guda as Anupana, most of the drugs are Vatanulomana and Sulahara in action.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
16.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • 1.Patients fulfilling the diagnostic criteria.
  • 2.Age between 16-35 years 3.Painful menstruation for at least previous 2 consecutive cycles, 4.Patients with regular menstrual cycles.

排除标准

  • 1.Cases of Secondary dysmenorrhoea with underlying pelvic pathology diagnosed by USG like Pelvic inflammatory disease, fibroids, endometriosis.
  • 2.Patient with intrauterine contraceptive devices 3.Patient’s on hormonal therapy 4.Patient with gastritis 5.Known case of HIV, HBsAg, VDRL.

结局指标

主要结局

To see the reduction in the insensitive of pain

时间窗: On completion of 2nd cycles and 3rd cycle

and associated symptoms

时间窗: On completion of 2nd cycles and 3rd cycle

次要结局

未报告次要终点

研究者

发起方
Dr ASWINI S
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验